In prostate adenocarcinoma, MEP50 stabilizes AR-p53 heterodimers at a subset of androgen-responsive genes, contributing to AR’s control over metastatic prostate cancer cell survival, apoptosis, and proliferation (6). This evidence concerns the gene AR and prostate adenocarcinoma.